Skip to content
Peptigraph home

SLU-PP-332 Side Effects: What Studies and Users Report

What FDA labels, clinical studies and people who use SLU-PP-332 report, how strong that evidence is, and what is still unknown.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureERR agonist (not a peptide)Updated

Side effects reported in studies

No side effects were reported in the study abstracts we summarised for SLU-PP-332 (PubMed search, 11 Oct 2026). Absence of reports is not evidence of safety: small and animal studies often do not measure or report harms.

What our search of PubMed and ClinicalTrials.gov found:

  • No named side effects of SLU-PP-332 were found in PubMed (2 records for the safety query on 11 October 2026): the hits are a systematic review of mouse and cell work and a review of nuclear receptor drugs, with no human data. No side effects can be listed.

What users report

Anecdotal evidence, 0 of 4

Side effects people describe from their own use of SLU-PP-332, quoted from 37 Reddit threads we read in r/PEDs, r/PeptideGuide, r/Peptides, r/Retatrutide and r/moreplatesmoredates (searched 11 Oct 2026). Each count is the number of different people in those threads, not how common the effect is. These reports are unverified: products bought outside a pharmacy are often mislabelled or impure, and many people take several compounds at once.

Side effects people report from using SLU-PP-332
What people noticedPeople reporting itIn their words
Feeling hot or sweating more4“I also sweat like a pig” r/Peptides, Apr 2026“Made me sweat like crazy.” r/Peptides, Dec 2025
Tiredness or lethargy3“would be exhausted and have to take naps in the middle of the day” r/moreplatesmoredates, Jan 2026“Fatigue, zero drive, even after stopping a week ago I still feel drained.” r/moreplatesmoredates, Oct 2025
Increased hunger2“my appetite was a lot higher” r/moreplatesmoredates, Jan 2026“Appetite is up (especially after bumping SLU and 5-Amino)” r/Peptides, Feb 2026Also taking other compounds
Low libido1“libido dropping hard” r/moreplatesmoredates, Oct 2025

A symptom others mention is not proof that it is harmless. If you have anything on the urgent list below, get care whatever others report.

What is not known

  • How common each effect is at the doses people use outside of studies.
  • Effects that take longer to appear than the length of the published studies.
  • How SLU-PP-332 interacts with other medicines and supplements.
  • Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.

When to get medical help

Get urgent care for: trouble breathing, swelling of the face or throat, a widespread rash, severe or lasting stomach pain, fainting, or an injection site that becomes hot, red and spreading.

This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.

Nothing is known in people

A systematic review of ERR agonists says safety and efficacy in humans remain to be shown by clinical trials.[8]

The same review reports that SLU-PP-332 and SLU-PP-915 reduced adiposity in obesity models without evident toxicity. These are preclinical models.[8]

A study of metabolites made in vitro from pooled human liver preparations looked at how the compound is broken down. It is not a study of side effects in people.[9]

In cultured myoblasts, SLU-PP-332 reduced cytotoxicity, oxidative stress and senescence. This is a cell result, not a safety finding for injection.[10]

Common questions

What are the side effects of SLU-PP-332?

No human side-effect data are cited. Obesity models in the review reported no evident toxicity, which is preclinical evidence only.[8]

What side effects do people who use SLU-PP-332 report?

In the 37 Reddit threads we read (11 Oct 2026), people most often described feeling hot or sweating more (4 people), tiredness or lethargy (3 people), increased hunger (2 people). These are unverified personal reports, often from products of unknown purity, and the counts are not rates.

Is SLU-PP-332 safe?

Unknown in people. Only animal and cell work is cited, and a systematic review says clinical trials are needed to confirm human safety.[8]

Is there a SLU-PP-332 human clinical trial?

A ClinicalTrials.gov search on the compound name returned a total count of 0 registered studies, so no human trial was found there.[11]

More on SLU-PP-332

Sources

  1. 1PubMed search: "SLU-PP-332"[tiab] (10 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  2. 2PubMed search: SLU-PP-332[tiab] OR SLU-PP-915[tiab] OR "ERR agonist"[tiab] AND exercise mimetic[tiab] (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  3. 3PubMed search: ("SLU-PP-332"[tiab] OR "SLU-PP-915"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  4. 4Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  5. 5Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
  6. 6Reddit thread in r/moreplatesmoredates (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  7. 7Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  8. 8[Pharmacological Activation of ERRα/β/γ as an Exercise Mimetic: Potential Therapeutic Applications].Revista medica de Chile · 2026PMID 42024694Accessed 2 Oct 2026
  9. 9Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes.Drug testing and analysis · 2026PMID 41688415Accessed 2 Oct 2026
  10. 10Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study.Frontiers in physiology · 2025PMID 40692696Accessed 2 Oct 2026
  11. 11clinicaltrials.gov: term SLU-PP-332 OR SLUPP332ClinicalTrials.gov · 2026clinicaltrials.govAccessed 25 Oct 2026

Found an error? Report a correction.